Francesco Fascetti-Leon1, Giovanni Scotton2, Luca Pio3, Raimundo Beltrà4, Paolo Caione5, Ciro Esposito6, Girolamo Mattioli7, Amulya K Saxena8, Sabine Sarnacki3, Piergiorgio Gamba2. 1. Pediatric Surgery Unit, Women's and Children's Health Department, University of Padova, Padova, Italy. francesco.fascettileon@unipd.it. 2. Pediatric Surgery Unit, Women's and Children's Health Department, University of Padova, Padova, Italy. 3. Department of Pediatric Surgery, Necker Enfants-Malades Hospital-Université Paris Descartes, Sorbonne Paris Cite, Paris, France. 4. Pediatric Surgery, Hospital Universitario Materno Infantil, Las Palmas, Spain. 5. Pediatric Urology, Ospedale Bambino Gesù, Rome, Italy. 6. Pediatric Surgery Unit, Department of Translational Medical Sciences, Federico II University, Naples, Italy. 7. Pediatric Surgery Unit, Istituto Giannina Gaslini, DINOGMI University of Genoa, Genoa, Italy. 8. Paediatric Surgery Department, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
Abstract
BACKGROUND: Minimal access adrenal surgery (MAAS) for adrenal pathologies is the standard for many pediatric surgical centers. However, the literature offers few reports and minimal evidence from small case series. The aim of this study was to evaluate the outcomes of pediatric MAAS through a multi-center data analysis. METHOD: Pediatric patients who underwent MAAS between January 2002 and December 2013 were retrospectively included. Data analysis was conducted using Spss software (Welch's t-test, X-square, Fisher tests, multiple regression model). RESULTS: Six European centers participated, 68 patients were included with mean age of 5.2 years (2 months-16 years). Lesion volume was of 18.1 cc (0.78-145.6), with a mean diameter of 2.8 cm (1.1-6.5). Localization was 50% left-sided masses, 45.6% right-side masses, and 4.4% bilateral. Histological examination revealed 36 neuroblastomas, 15 adenomas, nine pheochromocytomas, three ganglioneuromas, two ganglioneuroblastomas, one bilateral hyperplasia, one adrenocortical carcinoma, an alveolar sarcoma, and a calcification. Surgical access was transperitoneal in 63 (92.6%) and retroperitoneal in 5 (7.4%). Mean operative time was 170 ± 87 min (285 ± 30 min for bilateral lesions). Mean hospital stay was 4.2 ± 2.5 days. Complications included blood loss requiring transfusion in five patients (7.4%) and a diaphragmatic tear. Infiltration of surrounding structures correlated with intraoperative complication rate (p = 0.027) and operative time (p < 0.01). No mass rupture, conversion, or post-operative complications were observed. Median follow-up was 52 months (1-161). Two recurrences occurred in patients with pheochromocytoma. Age, weight, symptoms, characteristics at imaging, chemistry, volume, or histology, did not influence operative time, hospital stays, or complication rate. CONCLUSIONS: Pediatric MAAS was safe adopted for masses up to 145.6 cc, with a very low rate of complication. Conversion to open is not necessary even in the presence of infiltrations. MAAS should represent the first-line treatment for selected cases in centers experienced in laparoscopy.
BACKGROUND: Minimal access adrenal surgery (MAAS) for adrenal pathologies is the standard for many pediatric surgical centers. However, the literature offers few reports and minimal evidence from small case series. The aim of this study was to evaluate the outcomes of pediatric MAAS through a multi-center data analysis. METHOD: Pediatric patients who underwent MAAS between January 2002 and December 2013 were retrospectively included. Data analysis was conducted using Spss software (Welch's t-test, X-square, Fisher tests, multiple regression model). RESULTS: Six European centers participated, 68 patients were included with mean age of 5.2 years (2 months-16 years). Lesion volume was of 18.1 cc (0.78-145.6), with a mean diameter of 2.8 cm (1.1-6.5). Localization was 50% left-sided masses, 45.6% right-side masses, and 4.4% bilateral. Histological examination revealed 36 neuroblastomas, 15 adenomas, nine pheochromocytomas, three ganglioneuromas, two ganglioneuroblastomas, one bilateral hyperplasia, one adrenocortical carcinoma, an alveolar sarcoma, and a calcification. Surgical access was transperitoneal in 63 (92.6%) and retroperitoneal in 5 (7.4%). Mean operative time was 170 ± 87 min (285 ± 30 min for bilateral lesions). Mean hospital stay was 4.2 ± 2.5 days. Complications included blood loss requiring transfusion in five patients (7.4%) and a diaphragmatic tear. Infiltration of surrounding structures correlated with intraoperative complication rate (p = 0.027) and operative time (p < 0.01). No mass rupture, conversion, or post-operative complications were observed. Median follow-up was 52 months (1-161). Two recurrences occurred in patients with pheochromocytoma. Age, weight, symptoms, characteristics at imaging, chemistry, volume, or histology, did not influence operative time, hospital stays, or complication rate. CONCLUSIONS: Pediatric MAAS was safe adopted for masses up to 145.6 cc, with a very low rate of complication. Conversion to open is not necessary even in the presence of infiltrations. MAAS should represent the first-line treatment for selected cases in centers experienced in laparoscopy.
Authors: Piero Romano; Luigi Avolio; Giuseppe Martucciello; Henri Steyaert; Jean Stéphane Valla Journal: Surg Laparosc Endosc Percutan Tech Date: 2007-12 Impact factor: 1.719
Authors: Peter Nau; Sebastian Demyttenaere; Peter Muscarella; Vimal Narula; Jeffrey W Hazey; E Christopher Ellison; W Scott Melvin Journal: Surg Endosc Date: 2010-04-08 Impact factor: 4.584
Authors: H Steyaert; M Juricic; C Hendrice; M A Lembo; M Al Mohaidly; J Guitard; J S Valla Journal: Eur J Pediatr Surg Date: 2003-04 Impact factor: 2.191
Authors: Michael D Traynor; Alaa Sada; Geoffrey B Thompson; Christopher R Moir; Irina Bancos; David R Farley; Benzon M Dy; Melanie L Lyden; Elizabeth B Habermann; Travis J McKenzie Journal: Pediatr Surg Int Date: 2019-11-05 Impact factor: 1.827
Authors: Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle Journal: Ecancermedicalscience Date: 2022-02-17
Authors: Michaela Kuhlen; Christina Pamporaki; Marina Kunstreich; Stefan A Wudy; Michaela F Hartmann; Mirko Peitzsch; Christian Vokuhl; Guido Seitz; Michael C Kreissl; Thorsten Simon; Barbara Hero; Michael C Frühwald; Peter Vorwerk; Antje Redlich Journal: Front Endocrinol (Lausanne) Date: 2022-06-17 Impact factor: 6.055
Authors: Ahmed ElHaddad; Christoph Castellani; Erich Sorantin; Martin Benesch; Eva Kampelmühler; Georg Singer; Holger Till Journal: European J Pediatr Surg Rep Date: 2019-10-31
Authors: Eva M Dobrindt; Wolfgang Saeger; Hendrik Bläker; Martina T Mogl; Marcus Bahra; Johann Pratschke; Nada Rayes Journal: Rare Tumors Date: 2021-12-10